Acquisition Announced
Tarsus Pharmaceuticals acquisition of Alkeus Pharmaceuticals
US$450m consideration
Announced 6 Aug 2026
Advisers
- Target
- Alkeus Pharmaceuticals
- Acquirer
- Tarsus Pharmaceuticals
- Target based in
- United States
- Buyer based in
- United States
- Sector
- Biotech
- Tags
- Biotech, Ophthalmology, Drug Development
In the league tables
Similar deals
- Bayer acquisition of Perfuse Therapeutics May 2026 · US$300m · Biotech
- Treeline Biosciences and Standard BioTools merger Jun 2026 · US$460m · Biotech
- Werewolf Therapeutics and Ambros Therapeutics merger Aug 2026 · US$500m · Biotech
- Amneal Pharmaceuticals acquisition of Kashiv BioSciences Apr 2026 · US$375m · Biotech
- Eli Lilly and Company acquisition of CrossBridge Bio Apr 2026 · US$300m · Biotech
Sources
- Aug 2026 Latham Watkins Advises Alkeus Pharmaceuticals on Acquisition by Tarsus Pharmaceuticals lw.com
- 6 Aug 2026 Press release (EX-99.1, exhibit), Tarsus Pharmaceuticals to Acquire Alkeus Pharmaceuticals and Advance Eye Care Leadership Position Your publication date and time will appear here. | Source: Tarsus Ph sec.gov
- 6 Aug 2026 Tarsus Pharmaceuticals to Acquire Alkeus Pharmaceuticals gunder.com


